MarketPulse

Phase 1b trial

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Aclaris Advances Dual-Target Antibody into Asthma Study Following Dermatitis Trial Launch

Aclaris launches Phase 1b asthma trial for ATI-052, a dual-target antibody also in dermatitis trials. Results expected mid-2026.
ACRSclinical developmentatopic dermatitis
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Fulcrum's Pociredir Shows Strong Hemoglobin Gains in Sickle Cell Phase 1b Trial

Fulcrum's pociredir shows strong fetal hemoglobin gains in sickle cell Phase 1b trial, with 58% of patients reaching therapeutic levels and reduced pain crises.
FULCrare diseaseclinical trial results
GlobeNewswire Inc.GlobeNewswire Inc.··Serina Therapeutics

Serina Therapeutics Advances SER-252 Development With First Phase 1b Enrollee

Serina Therapeutics enrolls first patient in Phase 1b trial for SER-252, an apomorphine-based Parkinson's treatment. FDA alignment on regulatory pathway supports streamlined development timeline.
SERFDA clearancePhase 1b trial